Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers January 20, 2018
Pharmacy Choice - News - Front Page Healthcare News - January 20, 2018

Pharmacy News

 Front Page Healthcare News
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

1/20/18 - "Shape Memory Device with Temperature-Dependent Deflectable Segment and Methods of Positioning a Shape Memory Device within a Bone Structure" in...
"Shape Memory Device with Temperature-Dependent Deflectable Segment and Methods of Positioning a Shape Memory Device within a Bone Structure" in Patent Application Approval Process. By a News Reporter-Staff News Editor at Investment Weekly News A patent application by the inventors Linderman, Evan D.; Ray, John, filed on September 8, 2017, was ma
1/20/18 - 3rd Annual Clinical Trial Collaborations Event Comes to Boston in April 2018 [Tehran Times (Iran)]
-The Conference Forum is pleased to announce the launch of the 3rd annual Clinical Trial Collaborations conference in Boston on April 9-11, 2018. Industry veteran, Dr Jeremy Chadwick, Group VP, Clinical Development Operations, Shire Pharmaceuticals, and conference chair, Dr Murray Abramson address in a fireside chat what it takes to develop strateg
1/20/18 - Alexion Pharmaceuticals, Inc. (ALXN) Shares Bought by Factory Mutual Insurance Co. [Daily News Egypt]
Factory Mutual Insurance Co. increased its stake in Alexion Pharmaceuticals, Inc. by 104.5% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. Factory Mutual Insurance Co. owned approximately 0.16% of Alexion Pharmaceuticals worth $42,873,000 as of its most recent filing with the..
1/20/18 - Arimoclomol for NPC receives Rare Pediatric Disease Designation [Arab Times (Kuwait)]
Orphazyme A/S, a Danish biotech company listed on Nasdaq Copenhagen, with a late-stage, orphan-drug pipeline, today announced that arimoclomol has been granted rare pediatric disease designation by the US Food and Drug Administration for the treatment of Niemann-Pick disease Type C. Arimoclomol has now been granted orphan drug, fast track, and rare
1/20/18 - Arvinas Announces Research Collaboration and License Agreement with Pfizer Inc. for the Discovery and Development of Protein Degradation Drug...
By a News Reporter-Staff News Editor at Marketing Weekly News Arvinas LLC, a private biotechnology company focused on creating a new class of drugs based on protein degradation, announced a research collaboration and license agreement with Pfizer Inc. for the discovery and development of drug candidates using Arvinas' proprietary PROTAC Platform,
1/20/18 - Avera To Enroll First Patients in Landmark Lung Cancer Tri-Therapy Clinical Trial [Sudan Tribune]
This clinical trial that received the approval of the FDA is Averas latest collaboration as part its membership in the Worldwide Innovative Networking Consortium. This latest step in our collaboration with WIN represents one clinical trial but is part of our larger goal to revolutionize cancer care through personalized medicine, said Benjamin Solom
1/20/18 - Biohaven to begin clinical development of BHV-5000 to treat Rett syndrome [Sport360]
Biohaven Pharmaceutical Holding Company Ltd. and its wholly owned subsidiary, Biohaven Pharmaceuticals, Inc., announced that the US Food and Drug Administration has notified the company that it may proceed with its clinical investigation of BHV-5000. BHV-5000 is a low trapping, potent N-methyl-D-aspartate receptor antagonist licensed to Biohaven fr
1/20/18 - Clinical Trial Management Systems Market: Future Market Projections for Forthcoming Years
Albany, NY 01/19/2018 Lately, the global pediatric vaccination market has been exhibiting a robust growth. Various upcoming child healthcare programs by UNICEF and the WHO are likely to boost this market in the near future. North America, Europe, Asia Pacific, and the Rest of the World are the key regional markets for pediatric vaccines in th
1/20/18 - Clinicians Are Not Ready for Medicare's New Payment System
The survey results were announced today on the eve of the annual conference of the Alliance for Continuing Education in the Health Professions, where CME s role in the value payment movement will be a hot topic. Results point to a persistent lack of awareness and preparedness for the changes, despite 2 years of vigorous educational campaigns by
1/20/18 - Combination of Encorafenib, Binimetinib and Cetuximab Demonstrated an 8 Month Median Progression-Free Survival in BRAF-Mutant Colorectal Cancer in Updated Safety Lead-In Results from BEACON Phase 3 Trial
BOULDER, Colo. and CASTRES, France, Jan. 20, 2018/ PRNewswire/ Array BioPharma Inc. and Pierre Fabre today announced updated results from the 30 patient safety lead-in of the Phase 3 BEACON CRC trial evaluating the triplet combination of encorafenib, a BRAF inhibitor, binimetinib, a MEK inhibitor and cetuximab, an anti-EGFR antibody, in patients
1/20/18 - Digital Mammography Equipment Market 2017 Global Industry Analysis, Size, Growth and Forecast Report Up To 2022
MarketStudyReport.com Add New Report Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Digital Mammography Equipment Market 2017 Forecast to 2022 to its research database. The report presents a deep study of the m...
1/20/18 - Digital Patient Monitoring Devices Market Value Share, Supply Demand, Trends and Value Chain 2018-2023: Digital Patient Monitoring Devices Market Overview & Industry Landscape by Focusing On Top Key Vendors: Omron, AT&T, Inc, Phillips Healthcare, Air
Pune, India 01/19/2018 The research report, titled "Global Digital Patient Monitoring Devices Market" offers a clear understanding of the subject matter. Omron Corporation, AT&T, Inc, Phillips Healthcare, Airstrip Technologies, Inc., Athenahealth, Inc., St. Jude Medical, Welch Allyn, Medtronic Plc, GE Healthcare, Fitbit, Inc., Garmin, Jawbone
1/20/18 - District Court Awards $5 Million in Civil Penalties and Enters Permanent Injunction to Prevent Dr. Reddys Laboratories Inc. from Distributing Prescription Drugs Not in Child-Resistant Packaging [AlArabiya.net (United Arab Emirates)]
The Department of Justice announced today that a federal court in New Jersey imposed a $5 million civil penalty and entered a consent decree of permanent injunction against Dr. Reddys Laboratories Inc. Dr. Reddys is the North American subsidiary of Dr. Reddys Laboratories Limited, a pharmaceutical company headquartered in India. The case involves..
1/20/18 - Dry Powder Inhalers Market Trends & Opportunities with Forecast Up to
Albany, NY 01/19/2018 Dry powder inhalers are used to deliver drugs in dry powdered form to the lungs of patients suffering from respiratory disorders. Pulmonary drug delivery has been gaining attention and acceptance in the past few years in the treatment of respiratory disorders due to advantages such as faster drug absorption, high bioavai
1/20/18 - Ebola Treatment Market Research Report - Forecast 2016 - 2024: Ebola Treatment Market- Industry Value Forecast, Dynamics, growth, potential, segments, market share, Size, online PDF Report, Free Sample Copy, Future projection, Analysis, supply and de
New York, NY 01/19/2018 Ebola viral infection was first observed in The Democratic Republic of Congo in 1976. Ebola is a viral disease which frequently causes lethal haemorrhagic fever in humans. Top drug companies such as Hemispherx Biopharma, Biochryst Pharmaceuticals, Nano Vircides, Serepata Therapeutics, NewLink Genetics and Mapp Biopharm
1/20/18 - EC approves biosimilar bevacizumab for the treatment of certain types of cancer [Arab News (Saudi Arabia)]
Amgen and Allergan plc have that the European Commission has granted marketing authorisation for MVASI. The European Commissions approval of MVASI marks a significant milestone for both Amgen and the oncology community, providing a biosimilar for a medicine which is used across multiple types of cancer, said Sean E Harper, MD, executive vice presid
1/20/18 - Elsevier Acquires Via Oncology, Leading Provider Of Clinical Decision Support Solutions for Oncology Professionals
Elsevier issued the following news release:. Elsevier, the information analytics business specializing in science and health, and part of RELX Group, today announced that it has acquired Via Oncology, a Pittsburgh, Pennsylvania- based company that provides decision support and best practices in cancer care management. "Cancer centers need to provi
1/20/18 - Exelixis Announces Presentation of Updated Phase 1b Results for the Combination of Cobimetinib and Atezolizumab in Metastatic Colorectal Cancer at the 2018 American Society of Clinical Oncology Gastrointestinal Cancers Symposium
Exelixis, Inc. today announced the presentation of updated results from the Genentech- sponsored phase 1 b clinical trial of cobimetinib, an Exelixis- discovered MEK inhibitor, in combination with atezolizumab, an anti-PDL1 antibody discovered and developed by Genentech, a member of the Roche Group, in patients with metastatic colorectal cancer.
1/20/18 - Federal shutdown: What it means for Michigan [Detroit Free Press]
Jan. 20 LANSING The operations of state government would continue as normal in the event of a federal government shutdown, unless it extends beyond 30 days, an official said Friday. But Kurt Weiss, a spokesman for the Department of Technology, Management and Budget, said the state can keep large federally funded programs, such as Medicaid, runn
1/20/18 - Federal shutdown: What it would mean for Michigan [Detroit Free Press]
Jan. 19 LANSING The operations of state government would continue as normal in the event of a federal government shutdown, unless it extends beyond 30 days, an official said Friday. But Kurt Weiss, a spokesman for the Department of Technology, Management and Budget, said the state can keep large federally funded programs, such as Medicaid, runn
1/20/18 - Foresee Pharmaceuticals and Megapharm Announce License and Distribution Agreement
By a News Reporter-Staff News Editor at Marketing Weekly News Foresee Pharmaceuticals Co., Ltd., a Taiwan and US-based biopharmaceutical company and Megapharm Ltd., a leading Israel- based biopharmaceutical company, announced that they have entered into an exclusive license and distribution agreement for the commercialisation in Israel and the...
1/20/18 - Global Neonatal Ventilator Market SWOT Analysis, Benefits, Forthcoming Developments, Outlook, Research & Future Investments to : Global Neonatal Ventilator Market Outlook, Research, Trends and Forecast to 2021 with top key players - ACUTRONIC Medical
Houston, TX 01/20/2018 The Global Neonatal market will witness substantial growth due to increasing preterm birth rate and rising infant mortality in developing economies. In terms of revenue, the Global Neonatal Ventilator Market was valued at US$ 264.5 Mn in 2016 and is expected to reach US$ 467.8 Mn by 2025, expanding at a CAGR of 6.6% fro
1/20/18 - Hospitals worry about closures, layoffs as they brace for Medicaid funding changes [Chicago Tribune]
Jan. 20 It wasn't long ago that Charles Holland was giving opening-day tours of the gleaming outpatient center at St. Bernard Hospital in the Englewood neighborhood, built to bring a bevy of health care services and optimism to a community in need of both. Across the Chicago area, those institutions are worried that the revised funding formul
1/20/18 - Learn Details of the Genetic Testing Services Market Forecast and Segments, 2016 - 2023: Transparency Market Research Report Added "Genetic Testing Services Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 - 2023"
Albany, NY 01/19/2018 The study of genes has been detected as a highly dominant department of the healthcare industry, as it is at the backbone of several diseases as well as has the potential to pave a way of curing a number of them. The global market for genetic testing services has been projected to increment the demand at a healthy rate d
1/20/18 - Liquid Silicone Rubber Market to Witness Steady Expansion During 2017-2027: Future Market Insights has announced the addition of the Liquid Silicone Rubber Market to Witness Steady Expansion During 2017 - 2027" report to their offering.
Valley Cottage, NY 01/19/2018 Liquid Silicone Rubber Market: Overview. Silicone rubbers are elastomers composed of silicones and depending on the viscosity, are classified as solid silicone rubbers and liquid silicone rubbers. Liquid silicone rubbers are characterized by presence of relatively shorter chain, lower molecular weight polymers.
Articles(s): 1 - 25 of 250     Next >>     Go To Page:


© 2018 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2018 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415